503 related articles for article (PubMed ID: 27286042)
1. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection.
Broecker F; Klumpp J; Moelling K
Ann N Y Acad Sci; 2016 May; 1372(1):29-41. PubMed ID: 27286042
[TBL] [Abstract][Full Text] [Related]
2. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
[TBL] [Abstract][Full Text] [Related]
3. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
4. Stable core virome despite variable microbiome after fecal transfer.
Broecker F; Russo G; Klumpp J; Moelling K
Gut Microbes; 2017 May; 8(3):214-220. PubMed ID: 27935413
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
[TBL] [Abstract][Full Text] [Related]
7. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
8. Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation.
Broecker F; Klumpp J; Schuppler M; Russo G; Biedermann L; Hombach M; Rogler G; Moelling K
Cold Spring Harb Mol Case Stud; 2016 Jan; 2(1):a000448. PubMed ID: 27148577
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
[TBL] [Abstract][Full Text] [Related]
10. The success of fecal microbial transplantation in
Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
[No Abstract] [Full Text] [Related]
11. Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.
Seekatz AM; Theriot CM; Molloy CT; Wozniak KL; Bergin IL; Young VB
Infect Immun; 2015 Oct; 83(10):3838-46. PubMed ID: 26169276
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation to fight
Moelling K; Broecker F
Bacteriophage; 2016; 6(4):e1251380. PubMed ID: 28090385
[TBL] [Abstract][Full Text] [Related]
13. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
Tang G; Yin W; Liu W
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
Girotra M; Garg S; Anand R; Song Y; Dutta SK
Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
[TBL] [Abstract][Full Text] [Related]
15. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
16. A Practical Method for Preparation of Fecal Microbiota Transplantation.
Perez E; Lee CH; Petrof EO
Methods Mol Biol; 2016; 1476():259-67. PubMed ID: 27507347
[TBL] [Abstract][Full Text] [Related]
17. Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection.
Ray A; Jones C
Future Microbiol; 2016 May; 11():611-6. PubMed ID: 26986546
[TBL] [Abstract][Full Text] [Related]
18. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantations and the role of bacteriophages.
Liu Q; Xu Z; Dai M; Su Q; Leung Chan FK; Ng SC
Clin Microbiol Infect; 2023 Jun; 29(6):689-694. PubMed ID: 36414201
[TBL] [Abstract][Full Text] [Related]
20. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
